ChroMedX: ChroMedX Signs Deal to Acquire UX Data Sciences Corp.
ChroMedX Corp. (CSE:CHX) (OTCQB:CHXIF) (FSE:EIY2) (the "Company"), developer of the HemoPalm Handheld Blood Analyzer Platform, is pleased to announce that it has entered into a binding Letter-of-Intent ("LOI") to acquire Ottawa, Ontario based medtech data science company, UX Data Sciences Corp. ("UXD").The post ChroMedX Signs Deal to Acquire UX Data Sciences Corp. appeared first on Investing News Network.
Read full article »
ChroMedX is a medical technology company that focuses on developing medical devices for vitro diagnostics and point-of-care testing.
Read more